A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
Public ClinicalTrials.gov record NCT06909214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Open-Label, Prospective, Single-Group, Multicenter Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adult Participants With New-Onset Generalized Myasthenia Gravis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to measure how well adults with new-onset gMG (which means they've had generalized disease signs and/or symptoms for less than 1 year) respond to treatment with efgartigimod PH20 SC. The study consists of a treatment period of 51 weeks. The study duration for each participant will be approximately 58 weeks.
Study identification
- NCT ID
- NCT06909214
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 30 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 16, 2025
- Primary completion
- Jul 31, 2026
- Completion
- Apr 30, 2027
- Last update posted
- Mar 9, 2026
2025 – 2027
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, San Diego - Altman Clinical and Translational Research Institute (ACTRI) | La Jolla | California | 92037 | Recruiting |
| Samir Macwan, M.D., Inc. (S corporation) | Rancho Mirage | California | 92270 | Recruiting |
| EZR Research | Boca Raton | Florida | 33486 | Recruiting |
| University of Florida Jacksonville | Jacksonville | Florida | 32209 | Recruiting |
| Visionary Investigators Network | Miami | Florida | 33133 | Recruiting |
| University of California Irvine | Orange | Florida | 92868 | Recruiting |
| Medsol Clinical Research Center Inc | Port Charlotte | Florida | 33952 | Recruiting |
| Baycare Medical Group | St. Petersburg | Florida | 33705 | Recruiting |
| Emory Brain Health Center | Atlanta | Georgia | 30329 | Recruiting |
| The Queen's Medical Center - West Oahu | Honolulu | Hawaii | 96813 | Recruiting |
| Hawaii Pacific Neuroscience | Honolulu | Hawaii | 96817 | Recruiting |
| HSHS Medical Group | O'Fallon | Illinois | 62269 | Recruiting |
| UMass Memorial Medical Center | Worcester | Massachusetts | 01655 | Recruiting |
| Henry Ford Health System | Detroit | Michigan | 48202 | Recruiting |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Recruiting |
| Erlanger Neuroscience Institute | Chattanooga | Tennessee | 37403 | Recruiting |
| Central Texas Neurology Consultants - Elligo | Round Rock | Texas | 78681 | Recruiting |
| Center for Neurological Disorders - Greenfield | Greenfield | Wisconsin | 53228-1321 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06909214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2026 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06909214 live on ClinicalTrials.gov.